blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1632232

EP1632232 - Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile [Right-click to bookmark this link]
Former [2006/10]Salt of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile
[2007/46]
StatusThe patent has been limited
Status updated on  25.02.2022
Database last updated on 28.03.2026
Most recent event   Tooltip25.02.2022(Expected) limited patent specificationpublished on 30.03.2022  [2022/13]
Applicant(s)For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
[2022/13]
Former [2011/19]For all designated states
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse / BE
Former [2008/44]For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
Former [2006/10]For all designated states
JANSSEN PHARMACEUTICA N.V.
Turnhoutseweg 30
2340 Beerse / BE
For all designated states
Tibotec Pharmaceuticals Ltd.
Little Island
Co Cork / IE
Inventor(s)01 / Stevens, Paul, Theodoor, Agnes
c/o Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340, Beerse / BE
02 / Peeters, Jozef
c/o Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340, Beerse / BE
03 / Vandecruys, Roger, Petrus, Gerebern
c/o Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340, Beerse / BE
04 / Stappers, Alfred, Elisabeth
c/o Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340, Beerse / BE
05 / Copmans, Alex, Herman
c/o Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340, Beerse / BE
 [2022/13]
Former [2006/10]01 / Stevens, Paul, Theodoor, Agnes
c/o Janssen Pharmaceutica N.V. Turnhoutseweg 30
2340, Beerse / BE
02 / Peeters, Jozef
c/o Janssen Pharmaceutica N.V. Turnhoutseweg 30
2340, Beerse / BE
03 / Vandecruys, Roger, Petrus, Gerebern
c/o Janssen Pharmaceutica N.V. Turnhoutseweg 30
2340, Beerse / BE
04 / Stappers, Alfred, Elisabeth
c/o Janssen Pharmaceutica N.V. Turnhoutseweg 30
2340, Beerse / BE
05 / Copmans, Alex, Herman
c/o Janssen Pharmaceutica N.V. Turnhoutseweg 30
2340, Beerse / BE
Representative(s)Cornish, Kristina Victoria Joy
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2022/13]
Former [2012/34]UEXKÜLL & STOLBERG
Patentanwälte Beselerstraße 4
22607 Hamburg / DE
Former [2006/10]Vervoort, Liesbeth
Janssen Pharmaceutica N.V. Turnhoutseweg 30
2340 Beerse / BE
Application number, filing date05108086.902.09.2005
[2006/10]
Priority number, dateMY2004000357802.09.2004         Original published format: MY 0403578
WO2004EP5202803.09.2004         Original published format: PCT/EP2004/052028
EP2005010146725.02.2005         Original published format: EP 05101467
[2006/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1632232
Date:08.03.2006
Language:EN
[2006/10]
Type: B1 Patent specification 
No.:EP1632232
Date:11.05.2011
Language:EN
[2011/19]
Type: B3 Limited patent 
No.:EP1632232
Date:30.03.2022
Language:EN
[2022/13]
Search report(s)(Supplementary) European search report - dispatched on:EP08.11.2005
ClassificationIPC:A61K31/505, A61P31/18
[2006/10]
CPC:
A61K31/505 (EP,KR,NO); A61P31/18 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2022/13]
Former [2006/10]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL08.09.2006
BA08.09.2006
HR08.09.2006
MK08.09.2006
YU08.09.2006
TitleGerman:Salz von 4-[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitril.[2010/32]
English:Salt of 4[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile[2010/32]
French:Sel de 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile[2010/32]
Former [2006/10]Salz von 4-[[4-[[4-(2-Cyanoethenyl)-2,6-Dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitril.
Former [2006/10]Salt of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile
Former [2006/10]Sel de 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile
Examination procedure08.09.2006Examination requested  [2006/43]
25.10.2006Despatch of a communication from the examining division (Time limit: M04)
23.02.2007Reply to a communication from the examining division
09.08.2010Communication of intention to grant the patent
06.12.2010Fee for grant paid
06.12.2010Fee for publishing/printing paid
Opposition(s)Opponent(s)01  09.02.2012    ADMISSIBLE
Hamm, Volker
Hamm, Volker
Geibelstrasse 1
22303 Hamburg / DE
Opponent's representative
Wittkopp, Alexander
Maiwald Patentanwalts- und
Rechtsanwaltsgesellschaft mbH
Jungfernstieg 38
20354 Hamburg / DE
 [N/P]
Former [2012/11]
Opponent(s)01  09.02.2012    ADMISSIBLE
Hamm, Volker
Hamm, Volker
Geibelstrasse 1
22303 Hamburg / DE
Opponent's representative
Wittkopp, Alexander
Maiwald Patentanwalts GmbH Jungfernstieg 38
20354 Hamburg / DE
16.03.2012Invitation to proprietor to file observations on the notice of opposition
18.03.2012Invitation to proprietor to file observations on the notice of opposition
13.09.2012Reply of patent proprietor to notice(s) of opposition
20.09.2013Legal effect of rejection of opposition [2014/10]
20.09.2013Date of oral proceedings
15.10.2013Despatch of minutes of oral proceedings
15.10.2013Date of despatch of rejection of opposition
Limitations:22.11.2021Date of receipt of request for limitation
 admissible
20.01.2022Communication of intention to limit the patent
22.02.2022Fee for printing patent specification after limitation
Fees paidRenewal fee
01.10.2007Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
30.09.2009Renewal fee patent year 05
30.09.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PX] WO2005021001  (TIBOTEC PHARM LTD et al.) [PX] 1-6,9,15 * page 19, line 18 - page 21, line 13 *
 [DX] WO2004016581  (JANSSEN PHARMACEUTICA NV et al.) [DX] 1-17 * page 17 line 10; page 9, lines 25-31 - page 15, line 29 *
 [X] WO2004050058  (JANSSEN PHARMACEUTICA NV et al.) [X] 1-17 * page 19, lines 27-31 - page 29, line 5 *
 [DX] WO0016306  (SILICON IMAGE INC et al.) [DX] 1-17 * page 8, line 21; example B1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.